# Low-dose Propofol for the Treatment of Severe Refractory Migraine Headache in the Emergency Department

> **NCT02492295** · NA · TERMINATED · sponsor: **Albert Einstein Healthcare Network** · enrollment: 12 (actual)

## Conditions studied

- Migraine Headache

## Interventions

- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT02492295
- **Lead sponsor:** Albert Einstein Healthcare Network
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-08
- **Primary completion:** 2016-01-01
- **Final completion:** 2016-01-01
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Due to logistic reason
- **Last updated:** 2020-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02492295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02492295, "Low-dose Propofol for the Treatment of Severe Refractory Migraine Headache in the Emergency Department". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02492295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*